Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBIT Margin: 2010-2012

Historic EBIT Margin for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to -19.21%.

  • Sonoma Pharmaceuticals' EBIT Margin rose 6516.00% to -19.21% in Q4 2012 from the same period last year, while for Dec 2012 it was -22.35%, marking a year-over-year increase of 3043.00%. This contributed to the annual value of -50.75% for FY2012, which is 2620.00% up from last year.
  • As of Q4 2012, Sonoma Pharmaceuticals' EBIT Margin stood at -19.21%, which was down 6.41% from -18.05% recorded in Q3 2012.
  • Sonoma Pharmaceuticals' EBIT Margin's 5-year high stood at -12.22% during Q2 2012, with a 5-year trough of -105.83% in Q2 2010.
  • In the last 3 years, Sonoma Pharmaceuticals' EBIT Margin had a median value of -51.13% in 2011 and averaged -52.45%.
  • Over the last 5 years, Sonoma Pharmaceuticals' EBIT Margin had its largest YoY gain of 6,516bps in 2012, and its largest YoY loss of 85bps in 2012.
  • Sonoma Pharmaceuticals' EBIT Margin (Quarterly) stood at -89.84% in 2010, then spiked by 547bps to -84.37% in 2011, then surged by 6,516bps to -19.21% in 2012.
  • Its EBIT Margin stands at -19.21% for Q4 2012, versus -18.05% for Q3 2012 and -12.22% for Q2 2012.